Looking for volunteers
Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
NCT06445114 · Zachary Zumsteg · Updated 5 Aug 2026
- What is being tested
- Cisplatin
- For
- Oropharyngeal Cancer; Carcinoma
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years and older. About 50 people. The full rules are on the registry page.
- Where
- United States (4 sites)
- When
- Starts or started 12 May 2025, ends June 2032. Registered 6 June 2024.
- Results
- None posted yet.
In the researchers' words
This is a single institution phase II study that will enroll patients with T0-3N0-2 p16-positive oropharyngeal squamous cell carcinoma (OSCC) undergoing resection of all gross visible disease at the primary site and in the lymph nodes.
Sites
- Cedars-Sinai Cancer at Beverly Hills (THO)Beverly Hills, California, United States
- Cedars Sinai Medical CenterLos Angeles, California, United States
- CS Cancer at Valley Oncology Medical GroupTarzana, California, United States
- CS Cancer at the Hunt Cancer CenterTorrance, California, United States